Morgan Stanley Initiates Coverage On Imax with Overweight Rating, Announces Price Target of $63

Benzinga Newsdesk www.benzinga.com Positive 51.4%

Neg 0% Neu 0% Pos 51.4%

Morgan Stanley analyst Daniel Duran initiates coverage on Imax (NYSE:IMAX) with a Overweight rating and announces Price Target of $63.